Bimolecular fluorescence complementation demonstrates that the c-Fes protein-tyrosine kinase forms constitutive oligomers in living cells

Biochemistry

Volumn 48, Issue 22, 2009, Pages 4780-4788

  Shaffer, Jonathan M ^a   Hellwig, Sabine ^a   Smithgall, Thomas E ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVE STATE; COILED COIL; COLORECTAL CANCER; COMPLEMENTATION; CONFORMATIONAL CHANGE; EPITHELIAL CELLS; HIGH MOLECULAR WEIGHT; IN-VITRO; IN-VIVO; INTERCONVERSION; KINASE ACTIVITY; KINASE DOMAINS; LIVE CELL; LIVING CELL; MYELOID LEUKEMIA; N-TERMINAL; N-TERMINAL COILED-COIL REGIONS; NEURONAL CELL; OLIGOMERIC STATE; ONCOPROTEINS; PROTEIN-TYROSINE KINASE; SH2 DOMAIN; TUMOR SUPPRESSORS; TYROSINE KINASE;

AMINO ACIDS; CELL CULTURE; FLUORESCENCE; OLIGOMERIZATION; OLIGOMERS; ONCOGENIC VIRUSES;

CELL MEMBRANES;

ABELSON KINASE; OLIGOMER; PROTEIN KINASE FES; PROTEIN TYROSINE KINASE;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; ENZYME ACTIVITY; FLUORESCENCE; HUMAN; HUMAN CELL; NONHUMAN; OLIGOMERIZATION; ONCOGENE SRC; PRIORITY JOURNAL;

ANIMALS; BACTERIAL PROTEINS; CERCOPITHECUS AETHIOPS; COS CELLS; ENZYME ACTIVATION; GENE SILENCING; GENETIC COMPLEMENTATION TEST; HCT116 CELLS; HUMANS; IMMUNOBLOTTING; K562 CELLS; LUMINESCENT PROTEINS; MICROSCOPY, FLUORESCENCE; PROTO-ONCOGENE PROTEINS C-FES; SIGNAL TRANSDUCTION;

AVES; FELIDAE;

EID: 66649083460     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi900238f     Document Type: Article

References (43)

1. Greer, P. A. (2002) Closing in on the biological functions of Fps/Fes and Fer. Nat. Rev. Mol. Cell Biol. 3, 278-289.
2. Smithgall, T. E., Rogers, J. A., Peters, K. L., Li, J., Briggs, S. D., Lionberger, J. M., Cheng, H., Shibata, A., Scholtz, B., Schreiner, S., and Dunham, N. A. (1998) The c-Fes family of protein-tyrosine kinases. Crit. Rev. Oncog. 9, 43-62.
3. Cheng, H. Y., Rogers, J. A., Dunham, N. A., and Smithgall, T. E. (1999) Regulation of c-Fes tyrosine kinase and biological activities by N-terminal coiled-coil oligomerization domains. Mol. Cell. Biol. 19, 8335-8343.
4. Yu, G., Smithgall, T. E., and Glazer, R. I. (1989) K562 leukemia cells transfected with the human c-fes gene acquire the ability to undergo myeloid differentiation. J. Biol. Chem. 264, 10276-10281.
5. Cheng, H. Y., Schiavone, A. P., and Smithgall, T. E. (2001) A point mutation in the N-terminal coiled-coil domain releases c-Fes tyrosine kinase activity and survival signaling in myeloid leukemia cells. Mol. Cell. Biol. 21, 6170-6180.
6. Kim, J., and Feldman, R. A. (2002) Activated Fes protein tyrosine kinase induces terminal macrophage differentiation of myeloid progenitors (U937 cells) and activation of the transcription factor PU.1. Mol. Cell. Biol. 22, 1903-1918.
7. Laurent, C. E., Delfino, F. J., Cheng, H. Y., and Smithgall, T. E. (2004) The human c-Fes tyrosine kinase binds tubulin and microtubules through separate domains and promotes microtubule assembly. Mol. Cell. Biol. 24, 9351-9358.
8. Shibata, A., Laurent, C. E., and Smithgall, T. E. (2003) The c-Fes protein-tyrosine kinase accelerates NGF-induced differentiation of PC12 cells through a PI3K-dependent mechanism. Cell. Signalling 15, 279-288. (Pubitemid 36071672)
9. Kanda, S., Lerner, E. C., Tsuda, S., Shono, T., Kanetake, H., and Smithgall, T. E. (2000) The non-receptor protein-tyrosine kinase c-Fes is involved in FGF-2-induced chemotaxis of murine brain capillary endothelial cells. J. Biol. Chem. 275, 10105-10111.
10. Sangrar, W., Zirgnibl, R. A., Gao, Y., Muller, W. J., Jia, Z., and Greer, P. A. (2005) An identity crisis for fps/fes: oncogene or tumor suppressor?. Cancer Res. 65, 3518-3522. (Pubitemid 40616322)
11. Delfino, F. J., Stevenson, H. M., and Smithgall, T. E. (2006) A growth-suppressive function for the c-Fes protein-tyrosine kinase in colorectal cancer. J. Biol. Chem. 281, 8829-8835.
12. Shaffer, J. M., and Smithgall, T. E. (2009) Promoter methylation blocks FES protein-tyrosine kinase gene expression in colorectal cancer. Genes, Chromosomes Cancer 48, 272-284.
13. Bardelli, A., Parsons, D. W., Silliman, N., Ptak, J., Szabo, S., Saha, S., Markowitz, S., Willson, J. K., Parmigiani, G., Kinzler, K. W., Vogelstein, B., and Velculescu, V. E. (2003) Mutational analysis of the tyrosine kinome in colorectal cancers. Science 300, 949. (Pubitemid 36548874)
14. Itoh, T., and De, C. P. (2006) BAR, F-BAR (EFC) and ENTH/ ANTH domains in the regulation of membrane-cytosol interfaces and membrane curvature. Biochim. Biophys. Acta 1761, 897-912.
15. Boggon, T. J., and Eck, M. J. (2004) Structure and regulation of Src family kinases. Oncogene 23, 7918-7927. (Pubitemid 39468851)
16. Feldman, R. A., Lowy, D. R., Vass, W. C., and Velu, T. J. (1989) A highly efficient retroviral vector allows detection of the transforming activity of the human c-fps/fes proto-oncogene. J. Virol. 63, 5469-5474. (Pubitemid 19278791)
17. Greer, P. A., Meckling-Hansen, K., and Pawson, T. (1988) The human c-fps/fes gene product expressed ectopically in rat fibroblasts is nontransforming and has restrained protein-tyrosine kinase activity. Mol. Cell. Biol. 8, 578-587.
18. Rogers, J.A., Cheng, H. Y., and Smithgall, T. E. (2000) Src homology 2 domain substitution modulates the kinase and transforming activities of the Fes protein-tyrosine kinase. Cell Growth Differ. 11, 581-592.
19. Read, R. D., Lionberger, J. M., and Smithgall, T. E. (1997) Oligomerization of the Fes tyrosine kinase: Evidence for a coiled-coil domain in the unique N-terminal region. J. Biol. Chem. 272, 18498-18503.
20. Rogers, J. A., Read, R. D., Li, J., Peters, K. L., and Smithgall, T. E. (1996) Autophosphorylation of the Fes tyrosine kinase: Evidence for an intermolecular mechanism involving two kinase domain tyrosine residues. J. Biol. Chem. 271, 17519-17525.
21. Hu, C. D., Chinenov, Y., and Kerppola, T. K. (2002) Visualization of interactions among bZIP and Rel family proteins in living cells using bimolecular fluorescence complementation. Mol. Cell 9, 789-798. (Pubitemid 34454889)
22. Hu, C. D., and Kerppola, T. K. (2003) Simultaneous visualization of multiple protein interactions in living cells using multicolor fluorescence complementation analysis. Nat. Biotechnol. 21, 539-545.
23. Takashima, Y., Delfino, F. J., Engen, J. R., Superti-Furga, G., and Smithgall, T. E. (2003) Regulation of c-Fes tyrosine kinase activity by coiled-coil and SH2 domains: Analysis with Saccharomyces cerevisiae. Biochemistry 42, 3567-3574. (Pubitemid 36368651)
24. Nagar, B., Hantschel, O., Seeliger, M., Davies, J. M., Weis, W. I., Superti-Furga, G., and Kuriyan, J. (2006) Organization of the SH3- SH2 unit in active and inactive forms of the c-Abl tyrosine kinase. Mol. Cell 21, 787-798. (Pubitemid 43376129)
25. Nagar, B., Hantschel, O., Young, M. A., Scheffzek, K., Veach, D., Bornmann, W., Clarkson, B., Superti-Furga, G., and Kuriyan, J. (2003) Structural basis for the autoinhibition of c-Abl tyrosine kinase. Cell 112, 859-871. (Pubitemid 36378887)
26. Schindler, T., Sicheri, F., Pico, A., Gazit, A., Levitzki, A., and Kuriyan, J. (1999) Crystal structure of Hck in complex with a Src family-selective tyrosine kinase inhibitor. Mol. Cell 3, 639-648. (Pubitemid 29268447)
27. Sicheri, F., Moarefi, I., and Kuriyan, J. (1997) Crystal structure of the Src family tyrosine kinase Hck. Nature 385, 602-609. (Pubitemid 27087567)
28. Xu, W., Doshi, A., Lei, M., Eck, M. J., and Harrison, S. C. (1999) Crystal structures of c-Src reveal features of its autoinhibitory mechanism. Mol. Cell 3, 629-638. (Pubitemid 29268446)
29. Xu, W., Harrison, S. C., and Eck, M. J. (1997) Three-dimensional structure of the tyrosine kinase c-Src. Nature 385, 595-602. (Pubitemid 27087566)
30. Haigh, J., McVeigh, J., and Greer, P. (1996) The Fps/Fes tyrosine kinase is expressed in myeloid, vascular endothelial, epithelial and neuronal cells and is localized to the trans-golgi network. Cell Growth Differ. 7, 931-944. (Pubitemid 26360733)
31. Takahashi, S., Inatome, R., Hotta, A., Qin, Q., Hackenmiller, R., Simon, M. C., Yamamura, H., and Yanagi, S. (2003) Role for Fes/Fps tyrosine kinase in microtubule nucleation through is Fes/CIP4 homology domain. J. Biol. Chem. 278, 49129-49133.
32. McPherson, V. A., Everingham, S., Karisch, R., Smith, J. A., Udell, C. M., Zheng, J., Jia, Z., and Craig, A. W. (2009) Contributions of F-BAR and SH2 domains of Fes protein tyrosine kinase for coupling to the FcepsilonRI pathway in mast cells. Mol. Cell. Biol. 29, 389-401.
33. Briggs, S. D., and Smithgall, T. E. (1999) SH2-kinase linker mutations release Hck tyrosine kinase and transforming activities in rat-2 fibroblasts. J. Biol. Chem. 274, 26579-26583.
34. Smithgall, T. E., Yu, G., and Glazer, R. I. (1988) Identification of the differentiation-associated p93 tyrosine protein kinase of HL-60 leukemia cells as the product of the human c-fes locus and its expression in myelomonocytic cells. J. Biol. Chem. 263, 15050-15055.
35. Johnson, F. M., and Gallick, G. E. (2007) SRC family nonreceptor tyrosine kinases as molecular targets for cancer therapy. Anticancer Agents Med. Chem. 7, 651-659.
36. Hantschel, O., and Superti-Furga, G. (2004) Regulation of the c-Abl and Bcr-Abl tyrosine kinases. Nat. Rev. Mol. Cell Biol. 5, 33-44.
37. Sekar, R. B., and Periasamy, A. (2003) Fluorescence resonance energy transfer (FRET) microscopy imaging of live cell protein localizations. J. Cell Biol. 160, 629-633. (Pubitemid 36298259)
38. Li, J., and Smithgall, T. E. (1996) Co-expression with Bcr induces activation of the Fes tyrosine kinase and phosphorylation of specific N-terminal Bcr tyrosine residues. J. Biol. Chem. 271, 32930-32936.
39. Delfino, F. J., Shaffer, J. M., and Smithgall, T. E. (2006) The KRAB-associated co-repressor KAP-1 is a coiled-coil binding partner, substrate, and activator of the c-Fes protein-tyrosine kinase. Biochem. J. 399, 141-150. (Pubitemid 44505415)
40. c-fes) by its src homology 2 domain and major autophosphorylation site (tyr 713). Oncogene 8, 2283-2292.
41. Koch, C. A., Moran, M., Sadowski, I., and Pawson, T. (1989) The common src homology region 2 domain of cytoplasmic signaling proteins is a positive effector of v-fps tyrosine kinase function. Mol. Cell. Biol. 9, 4131-4140.
42. Weinmaster, G., Hinze, E., and Pawson, T. (1983) Mapping of multiple phosphorylation sites within the structural and catalytic domains of the Fujinami avian sarcoma virus transforming protein. J. Virol. 46, 29-41. (Pubitemid 13161241)
43. Filippakopoulos, P., Kofler, M., Hantschel, O., Gish, G., Grebien, F., Salah, E., Neudecker, P., Kay, L. E., Turk, B. E., Superti-Furga, G., Pawson, T., and Knapp, S. (2008) Structural coupling of Fes and Abl SH2-tyrosine kinase domains links substrate recognition and kinase activation. Cell 134, 793-803.